Objectives:  

Improve the development, management, awareness and uptake of the STGs and EML;
Improve understanding of HTA methodology and changes to the STGs and EML;
Expand the stakeholder database and develop lessons learned to improve communication;
Improve  equitable access and availability of essential medicines; and
Promote the rational use of medicine.

Speakers:

Ms Maropeng Rapetsoa
Pharmaceutical Policy Specialist
Essential Drugs Programme

Professor Karen Cohen
Primary Healthcare/Adult Hospital Level ERC Co-chair,
Associate Professor: Division of Clinical Pharmacology

Dr Jeremy Nel
Head: Infectious Diseases

Video: